Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
Hatta, Yoshihiro, Mizuta, Shuichi, Matsuo, Keitaro, Ohtake, Shigeki, Iwanaga, Masako, Sugiura, Isamu, Doki, Noriko, Kanamori, Heiwa, Ueda, Yasunori, Yoshida, Chikamasa, Dobashi, Nobuaki, Maeda, TomoyaLanguage:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-018-3323-8
Date:
April, 2018
File:
PDF, 1.02 MB
english, 2018